Arcus and Summit team up to test kidney cancer drug combo
Go back to Arcus and Summit team up to test kidney cancer drug combo| (NYSE: RCUS) | Delayed: 29.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.73 | 52 Week High | $ | |||
| Open | $29.73 | 52 Week Low | $ | |||
| Day High | $29.73 | P/E | N/A | |||
| Day Low | $29.73 | EPS | $ | |||
| Volume | 4,283 | |||||
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.98 | 52 Week High | $19.75 | |||
| Open | $14.98 | 52 Week Low | $4.26 | |||
| Day High | $14.98 | P/E | N/A | |||
| Day Low | $14.98 | EPS | $0.00 | |||
| Volume | 111,789 | |||||
